MedPath
NMPA Approval

Febuxostat Tablets

国药准字HJ20180051

August 21, 2023

H20180051

Drug Information

非布司他片

菲布力

片剂

20mg

化学药品

August 21, 2023

July 2, 2028

Company Information

Applicant Company

2-1, Kasumigaseki 3-chome, Chiyoda-ku, Tokyo

Manufacturing Company

teijin pharma limited iwakuni pharmaceutical factory

2-1, Hinode-cho, Iwakuni, Yamaguchi

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

非布司他片 - NMPA 批准文号 | MedPath